Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Compassionate Use of Azimilide in CHF
NCT00752596Phase 2Completed
- Sponsor
- Forest Laboratories
- Start
- Sep 2005
- Primary completion
- Jul 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of azimilide in heart failure (HF), sponsored by Forest Laboratories. Primary endpoints: Safety Assessment and No outcome measure. Started Sep 2005; status: completed.
02
Drugs
azimilide
03
Conditions
heart failure (HF)
Beyond the preview
Go deeper on NCT00752596.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00752596.